Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Payables (2019 - 2025)

Historic Payables for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $554000.0.

  • Outset Medical's Payables fell 8565.51% to $554000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $554000.0, marking a year-over-year decrease of 8565.51%. This contributed to the annual value of $554000.0 for FY2025, which is 8565.51% down from last year.
  • Outset Medical's Payables amounted to $554000.0 in Q4 2025, which was down 8565.51% from $1.7 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Payables registered a high of $6.8 million during Q1 2024, and its lowest value of $554000.0 during Q4 2025.
  • Over the past 5 years, Outset Medical's median Payables value was $2.5 million (recorded in 2021), while the average stood at $3.1 million.
  • In the last 5 years, Outset Medical's Payables surged by 86633.5% in 2023 and then tumbled by 8565.51% in 2025.
  • Over the past 5 years, Outset Medical's Payables (Quarter) stood at $1.8 million in 2021, then plummeted by 65.8% to $603000.0 in 2022, then surged by 866.33% to $5.8 million in 2023, then plummeted by 33.72% to $3.9 million in 2024, then crashed by 85.66% to $554000.0 in 2025.
  • Its Payables stands at $554000.0 for Q4 2025, versus $1.7 million for Q3 2025 and $1.4 million for Q2 2025.